| Postmenopausal osteoporosis – prevention and treatment |
| Osteoporosis in men |
| Glucocorticoid-induced osteoporosis |
| Paget’s disease of bone |
| Prevention of fractures in high-risk patients |
Tablet
Alendronate is a bisphosphonate medication used to prevent and treat osteoporosis in postmenopausal women and men, and to manage Paget’s disease of bone. It works by inhibiting bone resorption, thereby increasing bone mineral density.
| Speciality | Orthopedics | Endocrinology | Rheumatology |
|---|---|
| Tags | Osteoporosis | Paget’s Disease | Bisphosphonate | Bone Resorption Inhibitor |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.